Press releases

See all

Nov 19, 2024

Myriad Genetics Announces Prequel® Prenatal Screening Can Now be Performed Eight Weeks into Pregnancy

Read more

Nov 13, 2024

Myriad Genetics Expands Access to At-Home Early Fetal Sex DNA Test with Retail Launch

Read more

Nov 07, 2024

Myriad Genetics Reports Third Quarter 2024 Financial Results; Updates 2024 Financial Guidance

Read more

Nov 04, 2024

Myriad Genetics Comments on UnitedHealthcare’s Updated Medical Policy for Pharmacogenetic Testing

Read more

Public relations contacts

Glenn Farrell, Kate Schraml, Megan Manzari

pr@myriad.com

Investor relations contacts

Matt Scalo

ir@myriad.com
X social media icon Linkedin social media icon

About Myriad Genetics

Myriad Genetics is a leader in genetic testing and precision medicine, providing insights that help people take control of their health and enable healthcare providers to better detect, treat and prevent disease. 

  • Early insights helped Ashley prepare

    “Carrier screening empowers you to make the right decisions. Not only are you making a decision for yourself right now but you’re making a decision for the next 80, 90, 100 years to create a better life for you and your baby.”
  • Prenatal screening gave Hannah time to plan

    “Once we got the noninvasive prenatal screening results back, we were able to meet with a lot more physicians.”
  • How Prolaris provided clarity for his prostate cancer treatment plan

    “Prolaris gave me the ability to maintain the lifestyle that my wife and I have lived with for many years now.”
previous slide
    next slide